BHT.
A synthetic preservative that keeps supplements from going rancid on the shelf.
Reviewed March 2026
- Category
- General
- Also filed under
- Prevents oxidation of fats in supplement formulasExtends product shelf life
What BHT is, and what it does.
- Does it work
- Does its preservation job but offers zero health benefits.
- How much to take
- Not applicable. Trace amounts as a preservative.
- Time to feel it
- There's nothing here to notice. It acts on the oil in the capsule rather than on you, and its work shows up as a product that still tests clean at the end of its shelf life.
- The first dose
- On day one it's already working inside the capsule, holding off the reactions that turn oil rancid. It isn't taken up to do anything for you, so it has no onset of its own.
- With regular use
- Over months on a shelf it's what keeps a fish oil or a fat-soluble vitamin from oxidising, so the product still tests clean at the end of its dated life.
- How well tolerated
- FDA GRAS at food-use levels. Animal toxicity studies used doses orders of magnitude above supplement exposure.
- How it feels
- There's no subjective experience attached to it. Where it shows up is in the oil: no rancid smell, no off taste, and a batch that still meets spec later on.
- The overlooked benefit
- It evaporates at frying temperatures, so heat-treated systems pair it with a less volatile antioxidant. In a cold-filled softgel it stays where it was added.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
BHT has emerging evidence. Based on 23178+ studies.
- Effective food preservativeFDA GRAS designation
Questions people ask about BHT.
- Is BHT safe?
- At supplement doses, yes. FDA GRAS. The concerns come from animal studies using massive doses.
- Why is BHT in my supplement?
- To stop oils and fats from going rancid. Without it, your supplement would spoil faster.
- Can I find supplements without BHT?
- Yes. Many brands use natural alternatives like rosemary extract or vitamin E.
- Is BHT the same as BHA?
- They're cousins. Both synthetic antioxidant preservatives with different chemical structures.
- Does BHT have health benefits?
- Not at supplement doses. Some experimental antiviral research exists but that's not what it's doing in your multivitamin.
- Should I avoid BHT?
- At supplement levels, not a health risk. But dye-free options exist if it matters to you personally.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
The two hindered phenols differ in volatility and lipid partitioning, so used together they protect both the surface and the interior of a fat phase. This pairing is long-standing formulation practice.
Ascorbyl palmitate reduces the BHT phenoxyl radical back to the parent phenol, recycling the primary antioxidant and extending how long it keeps quenching lipid radicals.
Retinol and its esters degrade through radical attack on the polyene chain. BHT is routinely added to retinol premixes because it interrupts that chain and holds potency across storage.
Beta carotene's long conjugated chain is a ready target for peroxyl radicals, especially at higher oxygen levels. BHT scavenges those radicals first, so the carotenoid survives processing and shelf life.
Tocopherols work inside the lipid core while BHT is effective at lower concentrations across the phase. Combined phenolic systems suppress peroxide formation more durably than a single one.
BHT donates a hydrogen atom to the peroxyl radicals that propagate in EPA and DHA, which is why it appears in marine oil concentrates alongside tocopherols.
Once BHT donates its phenolic hydrogen to a lipid peroxyl radical it becomes a phenoxyl radical itself. Ascorbate reduces that radical back to the parent phenol at the oil and water interface, returning it to the pool. This regeneration chemistry is standard antioxidant theory and is why hydrophilic reductants are paired with lipophilic phenols.
Rosemary extract contributes carnosic acid and carnosol, phenolic diterpenes that break the same lipid autoxidation chain BHT interrupts. Formulators use them together or in place of one another when a plant-sourced label is wanted. Both act by hydrogen donation to peroxyl radicals.
Tocotrienols are chromanol phenols that terminate lipid peroxidation chains by the same hydrogen donation route as BHT, and their unsaturated tail distributes them differently within a membrane or oil phase. Combining phenols with different partition behaviour covers more of the lipid matrix. The chain-breaking chemistry is settled.
Krill oil carries long-chain polyunsaturated fatty acids with multiple bis-allylic hydrogens, the sites where autoxidation starts. A lipophilic chain-breaking phenol in the oil phase intercepts the peroxyl radicals that propagate that chain. This is the standard reason an antioxidant sits in a marine oil formula.
Alpha-linolenic acid has three double bonds and two bis-allylic positions, making flaxseed oil one of the more oxidation-prone edible oils. BHT is used at parts-per-million levels in such oils to extend the induction period before rancidity develops. The mechanism is radical chain termination in the lipid phase.
Evening primrose oil is rich in gamma-linolenic acid, a polyunsaturated fatty acid vulnerable to peroxidation during storage in a softgel. A lipid-soluble phenolic antioxidant slows that process by capping the propagating radicals. This is formulation practice grounded in oxidation chemistry.
DHA carries six double bonds and five bis-allylic methylene groups, so it oxidises faster than any other common dietary fatty acid. Antioxidant protection in the oil phase is what keeps peroxide and anisidine values within specification through shelf life. The chemistry is well established.
EPA has five double bonds and is subject to the same autoxidation chain as other long-chain polyunsaturates. A chain-breaking phenol at low concentration intercepts peroxyl radicals before they abstract hydrogen from another fatty acid. This protects the ingredient, and it says nothing about physiological effects.
Astaxanthin quenches singlet oxygen and scavenges radicals through its extended polyene chain, a different chemistry from the hydrogen donation of a hindered phenol. In an oil matrix the two address different initiation and propagation steps. Carotenoids are themselves oxidation targets, so they benefit from a phenol present alongside them.
Lycopene is a highly unsaturated acyclic carotenoid that degrades readily through oxidation and isomerisation during processing and storage. Antioxidant protection in the carrier oil preserves the declared carotenoid content to the end of shelf life. This is ingredient stabilisation rather than a nutritional interaction.
Lutein in a beadlet or oil suspension loses potency to oxidation of its polyene backbone. A lipid-phase chain-breaking antioxidant is included in the carrier to slow that loss. The role is protection of the active, not a change in how lutein behaves in the body.
Ubiquinol is itself a lipid-phase chain-breaking antioxidant and is oxidised to ubiquinone in the process, so a CoQ10 softgel oil needs its own oxidative protection. A hindered phenol in the carrier reduces that conversion during storage. The redox couple involved is well described.
Retinol and its esters have a conjugated polyene chain that oxidises and isomerises on exposure to oxygen, light and trace metals. Antioxidant addition to the oil phase is standard practice for holding label potency. The interaction is stability, not absorption.
Cholecalciferol degrades by oxidation and by thermal isomerisation in an oil carrier, which is why oil-suspension premixes carry an antioxidant. Protecting the carrier oil from going rancid also protects the vitamin dispersed in it. This is a stability role.
Lecithin phospholipids carry unsaturated acyl chains that oxidise, and lecithin is also described as an antioxidant synergist because its amino phospholipids can regenerate phenolic antioxidants and bind trace metal catalysts. Both roles appear in the same emulsion. The chemistry is documented in food science.
Sunflower lecithin is higher in linoleic acyl chains than soy lecithin and is correspondingly oxidation-prone, so an antioxidant travels with it in emulsified systems. It also contributes the metal-binding and phenol-regenerating behaviour attributed to phospholipids generally. This is an emulsifier and stabiliser pairing.
Linoleic acid has one bis-allylic position and is the reference substrate in most laboratory measurements of antioxidant chain-breaking activity. BHT slows peroxide formation in linoleate systems by donating hydrogen to the peroxyl radical. This is the textbook demonstration of how a hindered phenol works.
GLA-rich oils oxidise faster than monounsaturated carriers because each additional double bond adds a bis-allylic site. Antioxidant inclusion in the oil is what keeps peroxide value within specification. The relationship is between the antioxidant and the oil, not between two nutrients.
Squalane is the fully saturated form of squalene and is used as an oxidatively stable carrier oil, which is a different route to the same stability goal that an added phenol serves. Where unsaturated squalene is present instead, it oxidises readily and antioxidant protection matters more. The pairing is a carrier-system decision.
Talk to a doctor before taking BHT if any of these apply to you: Synthetic additive, High doses showed toxicity in animal studies, Some people prefer to avoid synthetic preservatives. These are flags to check first, not effects BHT is known to cause.
Not medical advice. Show the label to your pharmacist.What BHT actually does.
BHT is butylated hydroxytoluene, 2,6-di-tert-butyl-4-methylphenol, a sterically hindered monophenol that is oil soluble and essentially insoluble in water.
It acts as a chain-breaking antioxidant by donating its phenolic hydrogen atom to a lipid peroxyl radical, converting that radical to a hydroperoxide and halting the propagation step of autoxidation.
The two tert-butyl groups flanking the hydroxyl sterically stabilise the resulting phenoxyl radical, which is why the radical it forms is too unreactive to start a new chain.
BHT slows oxidation but does not inhibit microbial growth, so it is an antioxidant preservative rather than an antimicrobial one.
Where BHT comes from.
BHT is made in a chemical plant, not grown. Two small hydrocarbon groups are attached to a simple phenol molecule on either side of its reactive part, which is exactly what makes it good at soaking up the reactions that turn oils rancid. The mixture is then cleaned up by distillation and crystallised into white flakes.
Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.
Both are petrochemical intermediates; p-cresol comes from toluene or cumene chemistry and isobutylene from refinery C4 streams.
Isobutylene alkylates p-cresol at both positions ortho to the hydroxyl group under an acid catalyst such as sulfuric acid or an acidic ion-exchange resin, giving the 2,6-di-tert-butyl structure.
The catalyst is neutralised and washed out, and the product is distilled to separate it from mono-alkylated and over-alkylated by-products.
Purity is confirmed by melting point and chromatographic assay against the relevant food-chemical or pharmacopoeial specification.
The purified melt is crystallised and flaked or milled, then packed under conditions that keep it away from heat and light.
The forms it comes in.
The studies, linked.
6 sources behind our BHT verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialBHT-3009 Immunotherapy in Relapsing Remitting Multiple SclerosisClinicalTrials.gov ↗PHASE2 · 252 participants · Completed
- Clinical trialUtility of Breath-holding Test for Assessment of Pulmonary Disease Severity in Patients With Systemic SclerosisClinicalTrials.gov ↗NA · 120 participants · Completed
- Clinical trialA Randomized, Blinded, Placebo Controlled, Safety and Pharmacodynamic Study of BHT-3021 With Open Label Cross-Over in Subjects With Type I Diabetes MellitusClinicalTrials.gov ↗PHASE1 · 80 participants · Completed
- ClinicalTrials.gov ↗
- ClinicalTrials.gov ↗
- Clinical trialBuilding a Healthy Temple: a Diabetes Self-management Support Program in Hispanic Faith Community SettingsClinicalTrials.gov ↗NA · 360 participants · Unknown
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.